Brief: Daniel Farb Reports 7.87% Stake In Lumos Pharma As Of May 24, 2023
25/05/2023 17:18
May 25 (Reuters) - Daniel Farb :
* DANIEL FARB REPORTS 7.87% STAKE IN LUMOS PHARMA AS OF MAY
24,
2023 - SEC FILING
* DANIEL FARB : DISCUSSIONS WITH LUMOS PHARMA CONCERNING
CAPITAL
ALLOCATION HAVE BEEN PRELIM, EXPLORATORY, AND HAVEN'T RISEN TO
PLAN OR PROPOSAL
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)